(Q51776269)

English

ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.

scientific article published on 16 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

atherosclerosis

1 reference

based on heuristic

inferred from title

Richard M. Epand

11

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Vinod K. Mishra

object named as

Vinod K Mishra

7

0 references

author name string

Shaila P Handattu

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

David W Garber

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Dawn C Horn

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Donald W Hughes

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Bob Berno

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Alex D Bain

6

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Mayakonda N Palgunachari

8

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Geeta Datta

9

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

G M Anantharamaiah

10

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

language of work or name

0 references

publication date

16 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

282

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

1980-1988

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Apolipoprotein A-I and high-density lipoprotein: is this the beginning of the era of noninvasive angioplasty?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Apolipoprotein A-I mimetic peptides: potential role in atherosclerosis management

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

The double jeopardy of HDL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Apolipoprotein A-I mimetic peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

How high-density lipoprotein protects against the effects of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Molecular order in cis and trans unsaturated phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Two homologous apolipoprotein AI mimetic peptides. Relationship between membrane interactions and biological activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Antiatherogenic small, dense HDL--guardian angel of the arterial wall?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

The paraoxonase gene family and atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606231200

21 January 2018

Identifiers

10.1074/JBC.M606231200

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/17114186

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51776269&oldid=1251473865"